The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Open accessAbstract
BACKGROUND: Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling. METHODS: In a multicenter, double-blind, randomized trial, we assigned 970 patients with an acute anterior ST-segment elevation myocardial infarction (STEMI) who were undergoing percutaneous coronary intervention (PCI) within 12 hours after symptom onset and who had complete occlusion of the culprit coronary artery to receive a bolus injection of cyclosporine (administered intravenously at a dose of 2.5 mg per kilogram of body weight) or matching placebo before coronary recanalization. The primary outcome was a composite of death from any cause, worsening of heart failure during the initial hospitalization, rehospitalization for heart failure, or adverse left ventricular remodeling at 1 year. Adverse left ventricular remodeling was defined as an increase of 15% or more in the left ventricular end-diastolic volume. RESULTS: A total of 395 patients in the cyclosporine group and 396 in the placebo group received the assigned study drug and had data that could be evaluated for the primary outcome at 1 year. The rate of the primary outcome was 59.0% in the cyclosporine group and 58.1% in the control group (odds ratio, 1.04; 95% confidence interval [CI], 0.78 to 1.39; P=0.77). Cyclosporine did not reduce the incidence of the separate clinical components of the primary outcome or other events, including recurrent infarction, unstable angina, and stroke. No significant difference in the safety profile was observed between the two treatment groups. CONCLUSIONS: In patients with anterior STEMI who had been referred for primary PCI, intravenous cyclosporine did not result in better clinical outcomes than those with placebo and did not prevent adverse left ventricular remodeling at 1 year. (Funded by the French Ministry of Health and NeuroVive Pharmaceutical; CIRCUS ClinicalTrials.gov number, NCT01502774; EudraCT number, 2009-013713-99.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with relatively deceiving results (despite multiple clinical trials, no drug based on this concept has ever been approved for use in humans by regulatory agencies) [387].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [387]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authors Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Mario, C. D., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,890
Self-citationYellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C. A., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Belghiti, R. E., Cung, T. T., Bonnefoy‐Cudraz, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Self-citationEvolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & de Werf, F. V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,014
Self-citationMitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion
Griffiths, E. J., & Halestrap, A. P. (1995) · Biochemical Journal · doi:10.1042/bj3070093 · Cited by 838
Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy
Jolly, S. S., Cairns, J. A., Yusuf, S., Meeks, B., Pogue, J. M., Rokoss, M. J., Kedev, S. A., Thabane, L., Stankovic, G. R., Moreno, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415098 · Cited by 665
Self-citationSteg, P. G., Greenlaw, N., Tardif, J., Tendera, M., Ford, I., Kääb, S., Abergel, H., Fox, K. M., Ferrari, R., & on behalf of the CLARIFY Registry Investigators (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs289 · Cited by 653
Self-citationHausenloy, D. J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00455-8 · Cited by 585
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 714
Lactated Ringer's solution for preventing myocardial reperfusion injury
Koyama, T. (2017) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2017.03.002 · Cited by 13
Sonothrombolysis in the ambulance for ST-elevation myocardial infarction: rationale and protocol
Kadi, S. E., Porter, T. R., van Rossum, A. C., & Kamp, O. (2020) · Netherlands Heart Journal · doi:10.1007/s12471-020-01516-9 · Cited by 13
Door-to-unload: Left Ventricular Unloading Before Reperfusion in ST-elevation Myocardial Infarction
Parikh, M. J., Schuleri, K. H., Chakrabarti, A. K., O’Neill, W. W., Kapur, N. K., & Wohns, D. (2021) · Future Cardiology · doi:10.2217/fca-2021-0006 · Cited by 13
Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario
Kleinbongard, P., Lieder, H. R., Skyschally, A., & Heusch, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1173462 · Cited by 13
Cyclophilin D Modulates the Cardiac Mitochondrial Target of Isoflurane, Sevoflurane, and Desflurane
Harisseh, R., Chiari, P. C., Villedieu, C., Sueur, P., Abrial, M., Fellahi, J.-L., Ovize, M., & Gharib, A. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000479 · Cited by 13
Self-citationCorvoisier, P. L., Gallet, R., Lesault, P., Audureau, É., Paul, M., Ternacle, J., Ghostine, S., Champagne, S., Arrouasse, R., Bitari, D., et al. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0936-8 · Cited by 13
Self-citationNovel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI
Li, J., Sun, D., & Li, Y. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191105103417 · Cited by 13
Brenner, G. B., Giricz, Z., Garamvölgyi, R., Makkos, A., Onódi, Z., Sayour, N. V., Gergely, T. G., Baranyai, T., Petneházy, Ö., Kőrösi, D., et al. (2021) · Journal of Visualized Experiments · doi:10.3791/61901 · Cited by 13
Dziewierz, A., Zdzierak, B., Wańha, W., Luca, G. D., & Rakowski, T. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12120474 · Cited by 14
Li, K., Zhou, P., Li, J., Cheng, Y., Li, S., Wang, Y., Jiang, W., Bai, Y., Cao, H., & Wang, D. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121805 · Cited by 12
Kynurenic Acid: A Novel Player in Cardioprotection against Myocardial Ischemia/Reperfusion Injuries
Kamel, R., Baetz, D., Guéguen, N., Lebeau, L., Barbelivien, A., Guihot, A., Allawa, L., Gallet, J., Beaumont, J., Ovize, M., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16101381 · Cited by 12
Self-citationNecroptosis: a significant and promising target for intervention of cardiovascular disease
Ji, Y., Wen, X., Tang, H.-P., Su, W., Xia, Z., & Lei, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116951 · Cited by 14
Hu, Q., Zhang, J., Luo, X., Hu, P., Li, J., Li, F., Wang, Z., Zhang, S., Jiao, Z., Liu, Y., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.070936 · Cited by 13
Left Ventricular Unloading in Myocardial Infarction
Heusch, G., & Rassaf, T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.06.032 · Cited by 12
Advances in Ultrasound Therapeutics
Porter, T. R., Zeng, P., & Xie, F. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01563-7 · Cited by 12
Ismaeil, A., Babiker, F. A., & Al‐Sabah, S. (2022) · Pharmaceuticals · doi:10.3390/ph15060720 · Cited by 12
Mohammad, A., Babiker, F. A., & Al‐Bader, M. (2023) · Pharmaceuticals · doi:10.3390/ph16040492 · Cited by 12
New Drug Targets and Preclinical Modelling Recommendations for Treating Acute Myocardial Infarction
Cao, Y., Redd, M. A., Chen, F., Mizikovsky, D., Li, X., Macdonald, P. S., King, G. F., & Palpant, N. J. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.12.015 · Cited by 12
Heart rate and left ventricular adverse remodelling after ST-elevation myocardial infarction
Reindl, M., Reinstadler, S. J., Feistritzer, H., Tiller, C., Mayr, A., Klug, G., & Metzler, B. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.046 · Cited by 12
Novel risk factors for acute coronary syndromes and emerging therapies
Tong, D. C., Wilson, A., & Layland, J. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.148 · Cited by 12
Yusoff, S., Roman, M., Lai, F. Y., Eagle‐Hemming, B., Murphy, G. J., Kumar, T., & Wozniak, M. J. (2018) · Translational research · doi:10.1016/j.trsl.2018.11.002 · Cited by 12
Zhang, X., Qi, L., & Liu, Y. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.2.87 · Cited by 12
Cohen, M. V., & Downey, J. M. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419882923 · Cited by 12
Kang, L., Li, Y., Chen, K., Chen, X., Chu, Q., Zhao, X., & Li, R. (2024) · Medicine · doi:10.1097/md.0000000000040225 · Cited by 11
Xiao, F., Li, H., Wang, J., Wu, H., Cai, Y., Wang, J., Che, H., Li, G., Xia, Z., Xie, Y., et al. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02146-5 · Cited by 12
Can We Improve Myocardial Protection during Ischaemic Injury?
Ferrari, R., Biscaglia, S., Malagù, M., Bertini, M., & Campo, G. C. (2016) · Cardiology · doi:10.1159/000444847 · Cited by 11
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Sun, S.-J., Jiang, Y., Zhen, Z., Lai, W., Liao, S.-Y., & Tse, H. (2020) · Journal of Visualized Experiments · doi:10.3791/60392 · Cited by 11
New Nanoparticle Formulation for Cyclosporin A: In Vitro Assessment
Gendron, A., Tran, N. L. L., Laloy, J., Brusini, R., Rachet, A., Gobeaux, F., Nicolas, V., Chaminade, P., Abreu, S., Desmaële, D., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010091 · Cited by 11
Bellini, C., Antonucci, S., Morillas-Becerril, L., Scarpa, S., Tavano, R., Mancin, F., Lisa, F. D., & Papini, E. (2022) · Antioxidants · doi:10.3390/antiox11050907 · Cited by 11
Mitochondrial ROS production during ischemia-reperfusion injury
Prag, H. A., Kula‐Alwar, D., Beach, T. E., Gruszczyk, A. V., Burger, N., & Murphy, M. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00026-2 · Cited by 12
Al-Mawla, R., Ducrozet, M., Tessier, N., Païta, L., Pillot, B., Gouriou, Y., Villedieu, C., Harhous, Z., Paccalet, A., Silva, C. C. D., et al. (2020) · Cells · doi:10.3390/cells9051319 · Cited by 11
Self-citationBarajas, M. B., Wang, A., Griffiths, K. K., Matsumoto, K., Liu, R., Homma, S., & Levy, R. J. (2020) · Pediatric Research · doi:10.1038/s41390-020-1064-6 · Cited by 11
Buono, M. G. D., Damonte, J. I., Chiabrando, J. G., Markley, R., Turlington, J., Trankle, C. R., Kang, L., Biondi-Zoccai, G., Tassell, B. W. V., & Abbate, A. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001240 · Cited by 11
Ederoth, P., Dardashti, A., Grins, E., Brondén, B., Metzsch, C., Erdling, A., Nozohoor, S., Mokhtari, A., Hansson, M. J., Elmér, E., et al. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002104 · Cited by 11
Self-citationZhu, Z., Ling, X., Zhou, H., & Zhang, C. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9564 · Cited by 11
Duan, Z., Yuan, B., Li, H., Yang, J., Xiao, X., & Wei, K. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c00479 · Cited by 10
Cardioprotection in right heart failure
Boengler, K., Schlüter, K., SCHERMULY, R. T., & Schulz, R. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14992 · Cited by 10
Cullen, P. P., Tsui, S. S. L., Caplice, N. M., & Hinchion, J. (2020) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivaa333 · Cited by 10
Krawczyk, K., Stępień, K., Nowak, K. W., Nessler, J., & Zalewski, J. (2019) · Advances in Interventional Cardiology · doi:10.5114/aic.2019.90215 · Cited by 10
Choi, H., Han, J. H., Lim, S. Y., Lee, I., Cho, Y., Chun, E. J., & Lee, W. W. (2017) · Molecular Imaging · doi:10.1177/1536012117704767 · Cited by 10
Implicaciones clínicas, diagnósticas y terapéuticas de la psoriasis y enfermedad cardiovascular
Bonanad, C., González‐Parra, E., Rivera, R., Carrascosa, J. M., Daudén, E., Olveira, A., & Estrada, R. B. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2016.12.023 · Cited by 10
The application of remote ischemic conditioning in cardiac surgery
Bosnjak, Z. J., & Ge, Z. (2017) · F1000Research · doi:10.12688/f1000research.11018.1 · Cited by 10
Zhou, H., Ji, Y., Li, J., & Sun, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-72324-z · Cited by 9
Zuo, Y., Wang, J., Gong, Z., Wang, Y., Wang, Q., Yang, X., Liu, F., & Liu, T. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70236 · Cited by 9
Butt, N., Bache‐Mathiesen, L. K., Nordrehaug, J. E., Tuseth, V., Munk, P. S., Bonarjee, V., Hall, T. S., Jensen, S. E., Halvorsen, S., Firat, H., et al. (2017) · Cardiology · doi:10.1159/000475460 · Cited by 9
Cellular and molecular approaches to enhance myocardial recovery after myocardial infarction
Parviz, Y., Waleed, M., Vijayan, S., Adlam, D., Lavi, S., Nooryani, A. A. A., Iqbal, J., & Stone, G. W. (2018) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2018.05.021 · Cited by 9
Hong, J., Ge, H., Liu, J.-Q., Sun, R., & Kong, F. (2018) · Shock · doi:10.1097/shk.0000000000001296 · Cited by 9
Mitochondrial Protective Agents for Ischemia/Reperfusion Injury
Kloner, R. A. (2017) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.117.005805 · Cited by 9
The changing face after acute myocardial infarction
Bøtker, H. E. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0762-x · Cited by 9
Wang, Y., Wang, D.-H., Wei, W.-H., Xiong, X., Wu, J., Han, Z., & Cheng, L. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05112-y · Cited by 8
Zhan, W., Ahmad, M., Rongzhi, C., Fatima, S., & Shah, S. A. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101756 · Cited by 8
Myocardial Ischemia-Reperfusion and Diabetes: Lessons Learned From Bedside to Bench
Dia, M., Paccalet, A., Pillot, B., Léon, C., Ovize, M., Silva, C. C. D., Bochaton, T., & Paillard, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.660698 · Cited by 8
Self-citationPoh, B. M., Liew, L. C., Soh, Y. N. A., Lai, R. C., Lim, S. K., Ho, Y. S., & Soh, B.-S. (2024) · Stem Cells · doi:10.1093/stmcls/sxae015 · Cited by 8
Giblett, J. P., Clarke, S., Zhao, T. X., McCormick, L. M., Braganza, D. M., Densem, C. G., O'Sullivan, M., Adlam, D., Clarke, S., Steele, J., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.05.013 · Cited by 8
Clinical decision-making: Challenging traditional assumptions
Sara, J. D. S., Toya, T., Rihal, C. S., Lerman, L. O., & Lerman, A. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.10.077 · Cited by 8
Otterspoor, L., van Nunen, L. X., Veer, M. V. ’., Johnson, N. P., & Pijls, N. H. J. (2017) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2017.0006 · Cited by 8
Reperfusing the myocardium - a damocles Sword
Shah, V. K., & Shalia, K. K. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.11.009 · Cited by 8
on behalf of the DIRECTION investigators, Zhang, X., Tian, G., Shi, Z., Sun, Y., Hu, J., Jiang, Y., Zheng, R., Chen, S., Li, C., et al. (2020) · Trials · doi:10.1186/s13063-019-3947-6 · Cited by 8
Cyclosporine A Prior to Primary PCI in STEMI Patients
Chen-Scarabelli, C. A., & Scarabelli, T. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.024 · Cited by 8
Tonet, E., Bernucci, D., Morciano, G., & Campo, G. C. (2018) · Advances in Interventional Cardiology · doi:10.5114/aic.2018.74349 · Cited by 8
Lv, Y., Yu, Z., Zhang, P., Zhang, X., Li, H., Liang, T., Guo, Y., Cheng, L., & Peng, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1389953 · Cited by 7
Santana, B. R., García, J. S., y, A. J.-R., Cantolla, P., Fernández, M. G., López-Sendón, J., Tardif, J., Moreno, R., & Fernández‐Velasco, M. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120443 · Cited by 7
Cardioprotective Signaling: Outline and Future Directions
Jovanović, A. (2025) · Biomedicines · doi:10.3390/biomedicines13122973 · Cited by 8
Tassell, B. W. V., Wohlford, G. F., Buono, M. G. D., Damonte, J. I., Markley, R., Turlington, J., Kadariya, D., Talasaz, A. H., Ho, J., Marawan, A., et al. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001331 · Cited by 7
Acute-on-chronic inflammation in acute myocardial infarction
Matter, M. A., Tschaikowsky, T., Stähli, B. E., & Matter, C. M. (2024) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001176 · Cited by 7
Zhang, J., Wang, J., Wu, Y., Li, W., Gong, K., & Zhao, P. (2021) · International Heart Journal · doi:10.1536/ihj.20-439 · Cited by 7
Romeo, F. J., Mazurek, R., Sakata, T., Mavropoulos, S. A., & Ishikawa, K. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026474 · Cited by 7
Postconditioning with Lactate-Enriched Blood for Reducing Lethal Reperfusion Injury in Humans
Koyama, T. (2023) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-023-10372-y · Cited by 7
Zhabyeyev, P., McLean, B. A., Bassiouni, W., y Valencia, R. H., Paul, M., Darwesh, A. M., Seubert, J. M., Hazra, S., & Oudit, G. Y. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.022352 · Cited by 7
Ederoth, P., Grins, E., Dardashti, A., Brondén, B., Metzsch, C., Erdling, A., Nozohoor, S., Mokhtari, A., Hansson, M. J., Elmér, E., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012299 · Cited by 7
Self-citationOkada, K., Hibi, K., Kikuchi, S., Kirigaya, H., Hanajima, Y., Sato, R., Nakahashi, H., Minamimoto, Y., Matsuzawa, Y., Maejima, N., et al. (2022) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.122.014497 · Cited by 7
Hefler, J., Pawlick, R. L., Marfil‐Garza, B. A., Thiesen, A., Cuesta‐Gomez, N., Hatami, S., Freed, D. H., Karvellas, C. J., Bigam, D. L., & Shapiro, A. M. J. (2024) · Liver Research · doi:10.1016/j.livres.2024.02.002 · Cited by 6
Belosludtsev, K. N., Dubinin, M. V., & Belosludtseva, N. V. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297925602369 · Cited by 6
Huang, Y., Li, H., Xiong, J., Wang, X., Lv, J., Xiong, N., Liu, Q., 尹丽慧, Wang, Z., & Wang, Y. (2025) · Biomolecules · doi:10.3390/biom16010058 · Cited by 6
Sex Differences in Cardiac Tolerance to Oxygen Deprivation – 40 Years of Cardiovascular Research
Ošťádal, B., Drahota, Z., Hlaváčková, M., & Ostadal, P. (2024) · Physiological Research · doi:10.33549/physiolres.935429 · Cited by 6
Kuang, W., Huang, J., Yang, Y., Liao, Y., Zhou, Z., Liu, Q., & Wu, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0316463 · Cited by 6
Zeymer, U., Hassinger, F., Bramlage, P., Schäfer, A., Westermann, D., & Thiele, H. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.03.013 · Cited by 6
Parathyroid Hormone–Related Peptide
Datta, T., Przyklenk, K., & Datta, N. S. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417702976 · Cited by 6
Pharmacological Targeting of the Mitochondrial Permeability Transition Pore for Cardioprotection
Silva, F. S. G., Costa, C. F., Marques, R., Oliveira, P. J., & Pereira, G. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_20 · Cited by 7
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Fabris, E., Selvarajah, A., Tavenier, A. H., Hermanides, R. S., Kedhi, E., Sinagra, G., & Hof, A. W. J. V. ’. (2022) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-022-00531-y · Cited by 6
An Ultrastructural Perspective on Cell Death
Najdawi, Z. R., & Abu-Asab, M. S. (2022) · Jordan Medical Journal · doi:10.35516/jmj.v56i1.232 · Cited by 7
Quader, M. A., Akande, O., Cholyway, R. M., Lesnefsky, E. J., Toldo, S. A., & Chen, Q. (2023) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.03.088 · Cited by 6
Alexopoulos, P., Panoutsopoulou, K., Vogiatzis, G., Koletsis, E. N., Dougenis, D., & Tsopanoglou, N. E. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000492 · Cited by 6
Ayoub, I. M., Radhakrishnan, J., & Gazmuri, R. J. (2017) · PubMed Central · Cited by 6
Paccalet, A., Tessier, N., Paillard, M., Païta, L., Gomez, L., Gallo-Bona, N., Chouabe, C., Léon, C., Badawi, S., Harhous, Z., et al. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00393.2019 · Cited by 6
Self-citationSauer, F., Jesel, L., Marchandot, B., Dérimay, F., Bochaton, T., Amaz, C., Roubille, F., Cayla, G., Rioufol, G., García‐Dorado, D., et al. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaa005 · Cited by 6
Self-citationReperfusion Strategies in Acute Myocardial Infarction: State of the Art
Rangel, F. O. D. (2021) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20200226 · Cited by 6
Nanoparticle delivery of cardioprotective therapies.
Méndez‐Fernández, A., Cabrera-Fuentes, H. A., Velmurugan, B., Irei, J. S., Boisvert, W. A., Lu, S., & Hausenloy, D. J. (2020) · PubMed · Cited by 6
Hurdles to Cardioprotection in the Critically Ill
Hoe, L. E. S., Bartnikowski, N., Wells, M. A., Suen, J. Y., & Fraser, J. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153823 · Cited by 6
Liu, Y., Zhang, L., & Yang, Y. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.1.1005 · Cited by 6
Zhai, X., Liu, R., Li, J., Wang, F., Liu, L., Wei, S., Bian, Y., Pang, J., Xue, M., Qin, D., et al. (2022) · International Heart Journal · doi:10.1536/ihj.21-856 · Cited by 6
Acute Mechanical LV Unloading in Ischemia Reperfusion Injury
Ishikawa, K., & Meyns, B. P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.035 · Cited by 6
IL-4-Induced Gene 1: A Potential Player in Myocardial Infarction
Shen, R. D., Ding, Y., Dong, Q., Wang, Y., Yu, J. Y., Pan, C., Cai, Y., Li, Z., Zhang, J., Yu, K., et al. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2509337 · Cited by 5
Anti-inflammatory strategies for patients with atherosclerotic coronary disease
Imbesi, A., Greco, A., & Capodanno, D. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2564137 · Cited by 5
CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion
Noonan, J. E., Prijaya, S. A., Bienvenu, L. A., Dayawansa, N. H., Michla, M., Bongcaron, V., Sharma, P., Song, Y., Huang, A., Barbaro-Wahl, A., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf165 · Cited by 5
Kakavand, H., Saadatagah, S., Naderian, M., Aghakouchakzadeh, M., Jalali, A., Sadri, F., Amoli, A. I., Hosseini, S. H., Jenab, Y., Pourhosseini, H., et al. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02368-3 · Cited by 5
Qi, B., Li, T., Luo, H., Hu, L., Feng, R., Wang, D., Peng, T., Ren, G., Guo, D. S., Liu, M., et al. (2024) · MedComm · doi:10.1002/mco2.503 · Cited by 5
Alánová, P., Alán, L., Neckář, J., Ošťádal, B., & Kolář, F. (2024) · Physiological Research · doi:10.33549/physiolres.935427 · Cited by 5
Regression of Q waves and clinical outcomes following primary PCI in anterior STEMI
de Framond, Y., Schaaf, M., Pichot, S., Rangé, G., Dubreuil, O., Angoulvant, D., Claeys, M. J., García‐Dorado, D., Bochaton, T., Rioufol, G., et al. (2019) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2019.09.022 · Cited by 5
Self-citation
Metadata
- Authors
- Cung, T.-T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., Bonnefoy-Cudraz, E., Guérin, P., Elbaz, M., Delarche, N., Coste, P., Vanzetto, G., Metge, M., Aupetit, J.-F., Jouve, B., Motreff, P., Tron, C., Labeque, J.-N., Steg, P. G., Cottin, Y., Range, G., Clerc, J., Claeys, M. J., Coussement, P., Prunier, F., Moulin, F., Roth, O., Belle, L., Dubois, P., Barragan, P., Gilard, M., Piot, C., Colin, P., De Poli, F., Morice, M.-C., Ider, O., Dubois-Randé, J.-L., Unterseeh, T., Le Breton, H., Béard, T., Blanchard, D., Grollier, G., Malquarti, V., Staat, P., Sudre, A., Elmer, E., Hansson, M. J., Bergerot, C., Boussaha, I., Jossan, C., Derumeaux, G., Mewton, N., & Ovize, M.
- Affiliations
- Centre Hospitalier Universitaire de Nantes (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Lyon 1 Université (FR)
- Centre Hospitalier De Pau (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Saint-Joseph Saint-Luc (FR)
- Centre Hospitalier Intercommunal Aix-Pertuis (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Hôpital Charles-Nicolle (FR)
- CHU Dijon Bourgogne (FR)
- Antwerp University Hospital (BE)
- AZ Sint-Jan (BE)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Centre Hospitalier de Mulhouse (FR)
- HUmani - CHU Charleroi-Chimay (BE)
- Clinique du Millénaire (FR)
- Hôpital Privé Jacques Cartier (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Lille’s Cardiology Hospital (FR)
- Lund University (SE)
- ORCID
- Morel, Olivier
- Cayla, Guillaume
- Rioufol, Gilles
- Angoulvant, Denis
- Guérin, Patrice
- Delarche, Nicolas
- Coste, Pierre
- Motreff, Pascal
- Tron, Christophe
- Cottin, Yves
- Claeys, Marc J.
- Prunier, Fabrice
- Barragan, Paul
- Gilard, Martine
- Piot, Christophe
- Unterseeh, Thierry
- Sudre, Arnaud
- Hansson, Magnus J.
- Bergerot, Cyrille
- Jossan, Claire
- Mewton, Nathan
- Ovize, Michel
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-09-10
- Volume
- 373
- Issue
- 11
- Pages
- 1021-1031
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2200357463
- Cited by
- 713
- References
- 34
- Citations by year
- 2026: 38 · 2025: 46 · 2024: 48 · 2023: 55 · 2022: 62 · 2021: 57 · 2020: 75 · 2019: 79 · 2018: 70 · 2017: 70 · 2016: 92 · 2015: 20
- FWCI
- 66.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- HAL (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Lunds Universitet
- Assistance publique-Hôpitaux de Paris
- Universitair Ziekenhuis Antwerpen
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- cyclosporine, ST-elevation myocardial infarction, percutaneous coronary intervention, left ventricular remodeling, ischemia-reperfusion injury, myocardial infarct size, heart failure, intravenous cyclosporine, primary percutaneous coronary intervention, drug safety
- MeSH terms
- Peptidyl-Prolyl Isomerase D, Aged, Combined Modality Therapy, Double-Blind Method, Electrocardiography, Enzyme Inhibitors, Female, Heart Failure, Humans, Injections, Intravenous, Male, Middle Aged, Mortality, Myocardial Infarction, Cyclosporine, Ventricular Remodeling, Cyclophilins, Kaplan-Meier Estimate, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
